Actavis in 10 - PowerPoint PPT Presentation

1 / 14
About This Presentation
Title:

Actavis in 10

Description:

... (Good Manufacturing Practice) * Local GMP standards Actavis R&D sites ... India API Development Lorem ipsum 123 dolor sit Lorem ipsum 1 dolor ABC 57 ... – PowerPoint PPT presentation

Number of Views:122
Avg rating:3.0/5.0
Slides: 15
Provided by: ActavisG
Category:
Tags: actavis | india

less

Transcript and Presenter's Notes

Title: Actavis in 10


1
(No Transcript)
2
Actavis roots
3
Actavis strong growth
4
Actavis today
5
Actavis a true global player
  • International headquarters Zug,
    Switzerland, 30 km from Zürich
  • 29 nationalities in a staff of totally 150 people
  • Senior team and strategic functions based in one
    place

6
Actavis top 10 markets growth drivers
Top 10 markets Top 10 markets
Rank Markt
1 US
2 UK Ireland
3 Nordics
4 Russia
5 Germany
6 Romania
7 Turkey
8 Bulgaria
9 Netherlands
10 Serbia
Top 10 growth markets Top 10 growth markets
Market Growth
Saudi Arabia 241
Vietnam 166
Tunisia 68
Switzerland 61
Spain 51
Indonesia 50
Japan 50
France 49
Russia 39
Poland 13
By divisions
7
Actavis strong performance independent of market
types
Substitution marketsKey accounts
Prescription markets Branded for some time to come
Markets in transition
Actavis is well positioned to cope with key
requirements of different market types.
8
Actavis manufacturing network
Launch sites
High volume sites
Regional sites
Specialised sites
  • Malta 
  • Iceland 
  • Bulgaria Dupnitza 
  • India Alathur (finished 2013)
  •  
  • US Elizabeth 
  • UK Barnstaple
  • Russia Podolsk
  • China Foshan 
  • Indonesia Jakarta 
  • Serbia Leskovac 
  •  
  • Romania Bucharest (oncology)
  • Italy Nerviano (oncology) 
  • Bulgaria Troyan (SSL) 
  • USA Lincolnton (SSL)

All sites comply with FDA or EU/GMP (Good
Manufacturing Practice) Local GMP standards
9
Actavis RD sites
The 9 RD sites are supported by regulatory
centres in Iceland, Denmark, Bulgaria and the US,
as well as by local regulatory units.
10
Actavis strong pipeline
RD projects
In- licensing
DRA projects
Total pipeline

125
27
45
197
A total of 152 projects correspond to
125 molecules Current DRA projects
calculated per file only (not per country),
corresponds to approx. 180 product launches
719 product / markets launches (190 molecules)
in 2010
end 4Q 2010
11
Actavis people
End 2010

Europe 7,208
Americas 1,165
MEA and Asia Pacific 833
Medis 82
India 983
Corporate 346

  10,617
12
Thank you!
13
Editable map
To edit, click on the world map, then click
again on the country you want to edit
14
Thank you!
Write a Comment
User Comments (0)
About PowerShow.com